Xenacare (XCHO) Valuation Report 5-22-2010 with Chart

NOTICE: This report is an update with far more data available as of 5-22-2010. The original was written 12-15-2010 and publicly posted at that time of the XCHO discussion board on Yahoo and I-Hub. This is important as 6 months have passed since then that report in effect allowing an evaluation by anyone of the quality of the analysis performed at that time. Here is the original post on 12-15-2009 http://investorshub.advfn.com/boards/read_msg.aspx?message_id=44551225
At that time we were flying blind. We had no numbers from either company, we did not know what the deal was between XCHO and Partner NPHC, and distribution was barely starting with almost all sales being retail on XCHO own web: www.Cobroxin.com. Thus any projections were difficult at best. Surprisingly that report ended up being quite accurate considering the circumstances. We now have two 10Q reports from both companies as of yesterday. Hence a good time to update.

Today XCHO has a revenue rate rate of about $4 million a year based of prior Q and it is profitable, an amazing turnaround in a short period of time. At the time some NPHC investors were very critical of the projection in that report that XCHO's revenue from per unit Cobroxin sales would be much higher than NPHC's. Those criticisms were sincere but revealed a lack of familiarity of how business and distribution work. The author of this report has run businesses including a distribution business. With the 10Qs now out it is clear that XCHO's revenue is about 3 times higher than NPHC's per bottle sold to consumers. Today 90% of what we wanted to know and did not on 12-15-2009 we do now know. Making XCHO a far less risky investment.

To avoid confusion XCHO is not a pink-sheet stock, it is a fully reporting and audited NASDAQ Bulletin Board stock. Even though its price is small it follows the same basic accounting rules that larger companies like Apple Computer do. Pink-sheets stocks tend to be scams and rarely even report unaudited results. The difference safety wise is night and day.


XCHO Valuation Report:

There is an apparently lucrative investment in a company called Xenacare (XCHO) that is the exclusive distributor of Cobroxin (www.Cobroxin.com). Cobroxin is the first non-prescription pain med that can treat moderate pain (normally treated by Vicodin, Morphine or other opiates). The reason it is non-prescription is that there is no "high" thus it is non-additive and the dose is very small. The product was developed by Nutra Pharma (NPHC) which has already made a run in August-September 2009 of over 20 times based on the Cobroxin news.

I have pulled info from several sources into this report. In a nutshell their new pain killer Cobroxin has been placed in Winn-Dixie and on websites like Amazon as of 12-15-2009.

As of today Cobroxin is in distribution at:

AMAZON.COM
BENCHMARK
AMERIMARK
DR. LEONARD'S
KINNEY DRUG
DRUGSTORE.COM
CDMA
CVS
DERMADOCTOR
HARDTOFIND BRANDS
DRUG EMPORIUM
GNC
DUANE READE
MAX-WELLNESS
HANNAFORD
NATURAL HEALTH CENTER
HD SMITH
OVERSTOCK.COM
IMPERIAL DISTRIBUTORS
UNIVERSAL DIRECT (SUPPORT PLUS)
KERR DRUG
WALGREENS
VITAMIN PURITAN PRIDE
WINN DIXIE
QUICK2YOU
MUTUAL DRUG CO.

This includes the biggest drug store chains CVS and Walgreens both with about 7,000 stores each. Reports from the field say CVS has run out of Cobroxin on the shelves at many locations and that order points are being increased.

It appears to be a blockbuster OTC pain med, yet XCHO only has about a $16 million million market cap. Here are their Key financial Ratios on Yahoo. http://finance.yahoo.com/q/ks?s=XCHO.OB+Key+Statistics

The distribution store count has increased at a rather breathtaking pace. During the previous 60 days the number of stores stocking Cobroxin has increased by over 15,000. GNC with about 5,000 stores is signed up and is tagged in Cobroxin ads and will stock soon.

NPHC has released sales projections of 1,000,000 units a month. So far they say introductory sales are exceeding expectations. They have said by end of the 2Q of 2010 it will be on the shelf in 40% of the drug stores in America or about 40,000 stores. XCHO has exclusive marketing rights to Cobroxin. That projection made in December 2009 appears to be on target so far.


The CEO of Nutra Pharma Rik Deitsch http://people.forbes.com/profile/rik-j-deitsch/59117 has said in a webinar in September which is very informative on the technology the 1,000,000 units a month projection after it been fully rolled out. Here is that presentation: http://www.nutrapharma.com/investor_relations/presentations.php.

In January he gave this presentation at Small Cap Conference http://www.youtube.com/watch?v=9t6thagegyU which describes how Cobroxin modulates pain. It does not cause numbness, it just prevents the higher levels of pain sensation. He also gave a recent presentation at NASDAQ headquarters that reaffirmed those projections, if you multiple his sales figures in dollars by three (XCHO's revenue translation). Here is a video of that presentation http://www.mefeedia.com/watch/30948123


At this point NPHC's Cobroxin revenue is lower than XCHO's by a small amount because XCHO is building up inventory. But when XCHO orders match their sales in future, XCHO's revenue will be about 3 times higher.

BTW for full disclosure I have a position in both NPHC and XCHO although much larger a position in XCHO. I have increased that position significantly as more information has become available And the effectiveness of the product has been testified to from multiple sources including a MD.

Lets look at valuations. Currently NPHC has $85 million market cap and got to a $220 million market cap http://finance.yahoo.com/q/ks?s=NPHC.OB. They have 273 million shares out. Xenacare (XCHO) in comparison has a $16 million market cap and only 74 million shares out of which 56 million is float http://finance.yahoo.com/q/ks?s=xcho.ob. NPHC does have the advantage of additional drugs in the pipeline, but the gross sales of Cobroxin will first go to XCHO, then NPHC will get its cut. Since Rik uses the figure of 1 million bottles a month what will that translate into? XCHO is selling it briskly now online on its own site (www.Cobroxin.com) for $19. They wholesale for $10 from reports we have from a MD and others. Sites like Amazon.com, CVS.com and Overstock.com have had trouble keeping it stocked, it is selling apparently above their expectations. So to guess at Xenacare's (XCHO) average sales price I will use $11 a bottle. That is $132,000,000 in sales per year for a company with a market cap today of $16,000,000. Hence the opportunity. A rapidly growing company often gets a 5x or 8x Sales valuation. Lets say XCHO only gets a 3x Sales and the stock is diluted 25% as the PPS goes up. That would push XCHO from the current .21 to $4.95 per share. That would be a 23 bagger or 23 times current price. Lets say the CEO of NPHC is way off on his projections, and it is only 250,000 bottles a month. That would still be at a measly 3x Sales $1.24 a share or a 6 bagger.

If a 6X sales was the valuation then double those PPS targets. Stocks get undervalued and overvalued by rather spectacular amounts. It is more common for overvaluation in high growth stocks.

As the name implies the product is highly dilute peptides derived from cobra venom. The pain killing ability of this has been known for centuries and the US Army used it along side morphine in WW2. It was then unstandardized and the mechanism was unknown. Those issues have been solved. It works especially good on arthritis pain BTW. Cobroxin won Product of the Year when it was announced http://www.news-medical.net/news/20090831/Nutra-Pharmae28099s-Cobroxin-pain-reliever-is-Best-New-Product-at-the-ECRM-Conference.aspx. Here are some testimonials http://www.cobroxin.com/testimonials.php

Here are the notes from the 12-10-09 Webinar by Rik the CEO of NPHC. He said that up front it was not for investors but for users, but we got tons of news anyway.

1. Nyloxin OTC is foreign name of Cobroxin.

2. He said he was happy with Xenacare and how Cobroxin is being rolled out by Xenacare (XCHO).

3. He said by 2Q all major drug chains will have it and 40% of all drug stores in USA. This is on the shelf and it will result in 2Q sales explosion.

4. He gave us 5 retail chain names that have it on the shelf with close to 2,000 stores combined. The list is:
Winn Dixie 600 stores
Myers 173
Dwayne Reed 250 (NY)
Hannaford 250
Stop &Shop 375

BTW the CDMA already has ordered it and they have 6,000 outlets in 32 states: http://www.pr.com/press-release/191604

5. They do plan a pet version.

6. It is less expensive per month than Advil.

7. It is 5 micrograms per spray.

8. Overdose almost impossible, researcher drank 36 bottles and got double vision and headache only (oral ingestion neutralizes it to an extent, the spray enters the body through the throat).

9. TV ads will start running in January. In magazines now.

That list proved to be correct, every single one of those chains now stock Cobroxin plus the biggest chains such as CVS and Walgreens.


What Do Cobroxin Users have to Say?

Prior info we had as of 12-15-2009 was customer reviews at Amazon:

http://www.amazon.com/Cobroxin-Topical-Gel-60/product-reviews/B002VFYHGA/ref=cm_cr_dp_all_helpful?ie=UTF8&coliid=&showViewpoints=1&colid=&sortBy=bySubmissionDateDescending

Average Customer Review
5.0 out of 5 stars (5 customer reviews)
Most Helpful Customer Reviews

4 of 4 people found the following review helpful:
5.0 out of 5 stars Great new pain reliever, November 3, 2009
By Ruben Rivera (Minneapolis, MN USA) - See all my reviews
(REAL NAME)

I ordered this product several days ago and applied it according to the directions on joints that have been giving me chronic pain for years. The instructions say it takes 3 to 4 applications per day for about 4 days for it to become effective (then you can reduce the number of applications per day), but I was getting relief within a couple of days. Cobroxin is working great with none of the side effects the FDA says accompany many of the common pain relievers out there. This is great stuff.

4 of 4 people found the following review helpful:
5.0 out of 5 stars This product really works!, November 3, 2009
By A. Nel - See all my reviews
(REAL NAME)

I have purchased and used both the gel and the spray. I was a bit skeptic at first. It has been VERY effective on both a chronic elbow pain and the spray has worked wonders for my migraine problem.
There are no side effects associated with this product that one would get using over the counter drugs and prescription medications. It relieved me of serious pain within thirty minutes.


Thanks Cobroxin, awesome product!

2 of 2 people found the following review helpful:
5.0 out of 5 stars Cobroxin Works!!!!, November 3, 2009
By AlexD (Florida) - See all my reviews

Unbelievable. There is no other word to describe this product. I bought it for my girlfriend who has had pain in her hip for years. On only the second day after the first application, she walked to the grocery store not once, but twice, and without pain. Previously, she would get sore on the way there and suffer all the way back. This is one of those things that seems too good to be true, but is just THAT good. I'm so impressed, I already ordered more for two of my friends who suffer daily. I almost wish I had an ache of my own to try it out on!!


Since then here are two more Testimonials surprisingly on the only website that has attacked Cobroxin, in conjunction with Short Seller named Tim Sykes who apparently has a beef with Rik Deitsch of NPHC from the past

OK, James. I tried Cobroxin this week for the first time. I am a research coordinator in NC managing oncology clinical trials, and I have been managing clinical trials for 18 yrs. I also have chronic pain from degenerative disc disease. I am probably the worst skeptic ever, but Cobroxin does have an anesthetic/analgesic effect that Vicodin and other FDA-approved pain meds do not have without the associated side effects of narcotics. I had never heard of Cobroxin until I received a $2.50 coupon for it from CVS last week. I didn't even know what it was until I looked for it in the drug store. I thought it was a hoot and joked with the pharmacist about the remote possibility that it might have either severe side effects or that, if it didn't work, that I might know someone I would like to give it to as a gag gift. So far it has not given me a headache, but it has eased my back and shoulder pain a great deal, so that I can actually sleep at night. Why don't you create a sociological QOL trial for people who have tried it vs those who have not and see how the results stack up? I wonder how many other skeptics who have debilitating chronic pain would give Cobroxin a try. I'll bet quite a few.
You do know that the pharma industry isn't out to produce any easily-accessible long-term natural products that can be produced at a minimum of cost to the public, don't you??? Tee Hee.
May 18, 2010 12:36 PM

Anonymous said...
OK now I have you figured out! I posted a few weeks ago in which I asked you that if you truly wanted to know if Cobroxin worked, why don't you give it to 10 people you know and let them know that you think it is a BS product, but need their input, this way it wouldn't be swayed to create that placebo effect you speak of, it would be the total opposite. I said if you did that and honestly reported back your findings you would see first hand like I did. In that post, which you obviously deleted, I explained how I did exactly that and I bought 10 bottles of the spray and handed them out to those who were suffering from pain and told them I had to do a research paper on it and I needed their honest feedback, as it is presumed to be a marketing gimmick only. After 2 weeks 9 of the 10 people said it worked wonders and wanted to know where they could get more! I am summarizing here, because I was blown away by all the testimonials I got in regards to what type of pain it worked on and how well it worked! Now I know why you deleted that post and won't try what I suggested. I suppose this will get deleted too - Oh well at least I know who and what you are now! Cheers!
May 19, 2010 11:06 AM

Conclusion on efficacy: The reviews are overwhelmingly positive. I personally know one person who has had migraines for over 20 years and found relief with Cobroxin even though nothing else worked. Also another person that has Arthritis of the elbow and used the gel. She not only had pain relief, the pain never came back. It is to be noted that there are some people it does not work for. Rik of NPHC has said it does not work on 8% of patients.

There are indications that Cobroxin has curative effect on arthritis preventing further damage. Here is a list of scientific research on Cobra for pain relief: http://www.cobroxin.com/scientific_research.php. The Arthritis Foundation has accepted Xenacare as a sponsor. They have an excellent reputation and accept sponsorships from few companies. That relationship does indicate they have a good opinion of Cobroxin.


New developments Financial Data in 2010 for Xenacare:

They released both 2009 4thQ Annual Report (10K) and 2010 1st Q 10Q about the beginning of April 2010. The results were most encouraging. Here is the summation link on Yahoo: http://finance.yahoo.com/q/is?s=XCHO.OB

They went from only $8,000 in revenue in 3Q 2009 to $117,000 in 4th Q to $895,000 in 1st Q of 2010. The sequential sales growth of 4th Q to 1st Q is 665% and annual growth is over 1,400%. These are hyper growth type figures that most companies never achieve under any circumstances. Cobroxin has completely transformed Xenacare as a company. Even more amazing is that way ahead of expectations XCHO became profitable. This profitability of $109,000 in 1st Q shows that they have low overhead, high product margins and are good at spending wisely. Their Cost of Goods show a 68% profit margin on Cobroxin. Here is the complete report: http://yahoo.brand.edgar-online.com/DisplayFiling.aspx?dcn=0000943440-10-000264


Here is an Analysis of the 2010 1st Q and Projection for 2nd Q:

First what has XCHO the do in the past?

2007 $116k rev and 85k Cost of goods
2008 $121k rev and 89k Cost of goods
2009 $197k rev and 21k Cost of goods

Thus although revenue has grown in those three years, the amounts were small and in 2007 and 2008 the Cost of Goods was very high, while in 2009 very small, thus Gross Profit went up 450% while revenue went up 45% or one tenth as fast as Gross Profit. This is significant. The prior business model for SunPill was not working while in 2009 in which Cobroxin sales starting in just part of the 4th Quarter the business model for Cobroxin shines as totally different than that of the SunPill. To say the least this was a smart move on Xenacare's part. They went from less that 30% margins to about 90%. That was in retail (www.Cobroxin.com) only BTW, in distribution in 1Q is dropped to 68% which is still stellar.

Then in the 1st Quarter of 2010 they have jump started distribution with CVS starting to kick in at the end of the Quarter and Walgreens starting May1. The numbers for 1st Quarter are:

2010 1st Q $895k Revenue and $276k Cost of Goods and $619k Gross Profit

That is a sequential quarterly sales growth of 665% which is way beyond high growth. Hyper growth is the term to use for such growth. The distribution is going very well. The company deserves a lot of credit for getting into the two biggest drug chains in USA plus many other chains quickly. Their product margins are 68%, that is high for being in distribution, the 4Q was almost exclusively retail sales BTW. So the business model looks good so far. What about Net Profitability?

They went from a Net Loss of $1,011,000 in 2009 4Q to a positive $109,000 Net Profit in 2010 1Q. This was a shocker, no one ever thought they could be profitable that fast. They appear to have thrown any expense they could into the 4Q to clean up the books before staring the new year with a new business model. That is normal.

What about expenses? The Yahoo summation says $470,000 Selling and G&A and $35,000 interest. The 10Q was more detailed, Selling and Marketing was $370,260 and General and Adm was just $99,687. The G&A expense is rather amazing. There new business model is based on using commissions and outsourcing for many of the costs, and maintaining very low overhead. This has not only reduced the capital required it has reduced expenses a lot compared to if they tried to do the selling and packaging and shipping in-house. I applaud this business model. Have seen other companies stunt themselves, reduce profitability and increase the risk of failure by trying to do everything themselves even though they had a good product.

So with the info the company has put out in last two weeks trying to project the 2Q is easier.

After reading the NPHC 1Q 10Q which is just out, and knowing how much inventory XCHO has built up helps us guess 2Q sales. Also noting that CVS and Walgreens have not rolled it out in all stores at the same time (by visiting stores) will at this point guess the 2nd Q XCHO Revenue as coming in at $2.4 Million. In regard to this although it is a $19 product when they sell a company like CVS or Walgreens it could be a $200,000 order or a $400,000 order. Thus how the shipping dates fall makes projections very hard.

If G&A was $99k in 1st Q would guess it should not be over $150k in the 2nd Q so will use $150k.
Selling and Marketing will go up more than G&A, IMHO. Part of this is they have more money to spend, plus now that it is in big chains like CVS it makes far more sense to advertise it as before the only convenient place to buy it was online. If they had a lot of money to burn they could have had a big ad budget in 4thQ, but the efficiency of those ad dollars would have been much less than it is now. Now they can tag CVS and Walgreens in their ads and who knows what other chains in the 2Q. So as have guessed a 200%+ Revenue growth for 2010 2nd Q sequentially will venture that Selling and Marketing will increase by almost that much or 140% from $370,260 to $888,624 in 2nd Q. For Cost of Goods will guess with higher % in Distribution that Product Margin will drop to 62% or Cost of Goods of $912,000.

Thus will guess that Xenacare's 2nd Quarter 2010 as: (this is very hard in hyper-growth company to do, so reader beware):

2010 2nd Quarter

Revenue $2,400,000

Cost of Revenue $912,000

Selling and Mrktng $ 888,624

General and Adm $ 150,000

Interest Expense $ 35,000

Total Expenses $1,985,624

Net Profit Pretax $ 414,376 which is a 280% Sequential Profit Growth.

It appears if that even if growth rate even slows down, XCHO is currently selling for less than 1 P/E in 2011.


Again I am not and insider and even the insiders would have a hard time predicting these things so beware.


Here is an Analysis for NPHC's 1st Q 2010:

They reported after XCHO by 7 weeks. Here is the key numbers: Net sales for the three months ended March 31, 2010 were $864,424 compared to $18,230 for the three months ended March 31, 2009. The increase in net sales is due to the fact that during the quarter ended March 31, 2010, our net sales consisted solely of sales of our consumer product Cobroxin, which we began selling in the fourth quarter of 2009. Our net sales for the three months ended March 31, 2009 were generated from the provision of clinical research services to independent third parties.
Cost of sales for the three month period ended March 31, 2010 was $402,542 compared to $260 for the three month period ended March 31, 2009. Our cost of sales includes the direct costs associated with the manufacturing of Cobroxin. Our gross profit margin for the three month period ended March 31, 2010 was $461,882 or 53.4%. A comparison of gross profit from 2010 to 2009 is not meaningful since we did not sell Cobroxin during the quarter ended March 31, 2009.


This means that in 1Q that XCHO bought that much from NPHC, which is less than XCHO sold but close. Being XCHO sells per unit for 3 times NPHC's price that means XCHO built up inventory. They have to, when CVS orders that have to be able to ship fast, not order from NPHC.

So what it indicates is that XCHO expects to sell quite a bit in 2Q but even insiders can not predict in such fast growth environment. So yes it looks good for XCHO, but not guarantee.

For NPHC now we can really figure things out. NPHC's margins are less than XCHO's, that is in the cost of goods for them in report.

So original guesses back in Dec have ended up being surprisingly accurate.

Roughly it looks like XCHO sells wholesale for $10, buys for $3, NPHC sells for $3 and their costs are $1-$1.50. NPHC is getting a big benefit from inventory buildup by XCHO and will continue to in 2010.

NPHC has much higher overhead and research costs, thus was unable to make a profit in 1Q. They do have lower marketing costs, basically nil.

So the original guess that XCHO will make far more profit if Cobroxin is a big success and that XCHO revenue from Cobroxin in the long run will be higher than NPHC has been proved out by looking at revenue versus cost of goods. We were flying blind back then, now its not too hard to figure out.

Only one thing really has to go well for XCHO for it to be big success, that is Cobroxin being successful. We know the deal and cost structure now.


Danger Factors or Negatives for XCHO?

Back in December 2009 there was many danger factors, we did not know if they could get the distribution they thought they could, whether they would have to do massive dilution to stay afloat, if there was enough product margins to make a profit even at high sales figures, would people buy it, etc. All of those have gone away, their balance sheet is dramatically better than then. Here is the balance Sheet as of 1Q 2010: http://finance.yahoo.com/q/bs?s=XCHO.OB Their cash is up to $537,000 from $225,000 in prior Q (4th), Net Receivables are up to $792,000 from $30,000, debt is down and they have a positive balance sheet for the first time. What dangers remain?

1.The main one is that Cobroxin does not succeed, even though it seems to be. If it succeeds it is not easy to see how XCHO stock will not produce rather spectacular investment results.
2.The current low price in XCHO stock will hurt if they have to raise money. Being they are profitable and have high margins helps a lot on this. But if XCHO was .75 instead of .21 if they had to sell stock it would be better. Their dilution so far has been less than expected and far less that NPHC has done.
3.They are unknown as a stock, this is the primary cause for #2, They have as of last week hired for the first time an IR form, in fact two. One in Precision IR, more on this later.
4.If NPHC gets into trouble, it could cause problems, although probably ones that can be dealt with.
5.They currently are quoted on most online brokers with Bid/Ask Spreads that are much larger than reality. Management has talked to NASDAQ about this, and they say they can do nothing about it. TD, Fidelity and Schwab are three that have bad quotes. Interactive Brokers does have good quotes and this free link has good quotes too. Here is a free good quote http://www.otcmarkets.com/pink/quote/quote.jsp?symbol=xcho#getQuote

Positives for XCHO?

1.The product is recession proof. People in pain will buy a $19 OTC pain med even if they are in credit card troubles. How are people forced into false confessions and giving up national secrets? The ultimate weapon to get someone to do something is pain, torture. Buying a $19 product it nothing compared to what people will do to avoid pain.
2.Competition is dangerous and has side effects This is just not Vicodin and Morphine, all the competitors have this problem. Tylenol kills more people that Cocaine does. Tylenol is the #1 reason for people going to ER rooms in USA. It may be banned and recently some versions of it were banned for children. In the last year a FDA panel votes to eliminate Vicodin, Percocet, reduce Tylenol. Tylenol causes liver and kidney failure, IMHO it should be banned. The recommendations by panel are normally followed by FDA. Here is the report on the danger of the competition on MSNBC: http://www.msnbc.msn.com/id/31664450/ns/health-more_health_news/
3.The management is clearly very financially responsible. Just the online sales of Cobroxin at retail (they make about $18 a bottle profit as they make a profit on shipping , sell for $19 and buy for $3 roughly) covers there entire G&A costs per month.
4.It is a very simple business. Now that they have big distribution all that has to go right is that the product sells. Other companies may need 5 factors to go right to survive. XCHO is profitability in their first Q in distribution in contrast.

More on the issue of just needing one thing to go right:

I have been involved with a variety of companies from start-ups to public companies and being from Silicon Valley have watched maybe 25 more from the sidelines.

The case often is if A goes right, and B goes right, and C company does not try and squash us as a competitor, and if economy does not dive, and if we can raise another $20 million in next 10 months, and the FDA trials go well this company will have a highly successful product on the market in 3 years.
The above is not a joke, that is typical of a bio-tech company getting millions of funding. And a majority never make a dime. The reason is so many things have to go right, and if one link breaks like Phase 3 trials or funding, or bigco beating you to market the whole thing goes poof.

I have avoided such companies, but the above is a fairly typical case.

How about Xenacare? To get to $5 or maybe $10 a share it needs to maintain the current rate of growth as is expected for 9 months. That is it.

1. It is to market already. Already approved.

2. It has huge distribution with the biggest drug store chains there are, as of the last 30 days. And more is expected soon.

3. It has great competitive advantages over competitors such as liver and kidney killing Tylenol.

4. It has an exclusive marketing agreement.

5. It is ahead of schedule.

6. What is more recession proof than a $19 pain killer that lasts a month, that is $0.65 a day. A person in pain will buy a pain reliever before food.

They are waiting on nothing. No funding, no approval, nothing.

We do not need any foreign sales, other products, nothing. That would be gravy.

It is the lack of obstacles and depending on others that makes this so likely to be a 10-20 bagger from here IMHO. Only one thing has to go right, and when we see on the shelf at CVS and other places the evidence is that one and only one thing we need to happen, is happening already.

How does XCHO compare to other Hyper Growth Stocks?What is Fastest Growing Profitable Company Is?

Used http://www.stockscreen123.com/ which is highly capable screen that is free, at least at first. Looked for the fastest growing stocks that are Profitable.

XCHO was not on the list, but qualified, guessed because was not seeing 1Q data yet. Emailed them about it and got quick reply, impressive customer service. They said I was right on that, that Reuters hand updates all data to avoid machine errors, and they start with biggest companies first and had not got to XCHO yet, but indeed XCHO would then make the screen list.

This is the Screen
1. Y/Y Q Sales Growth > 500%
2. Profitable
3. Sequential Growth Q/Q > 500%

XCHO exceeds all three.

The concept of this is to find hyper growth stocks that are also profitable.

As of today BDSI, CFMI, CRME, EDS, GTXI, LECT, NRDS, PTN so there are 8 on the list now. But if you check them out they are mostly bio-techs that had no revenue, then they sold rights to a drug, a one time event, and appear they will go back to no revenue. NRDS and PTN are the exceptions, NRDS is a copper miner that is in default on copper hedges. And PTN is a bio tech that does seem to have recurring revenue. But shortly after running the screen PTN reported 1Q and it was a bad Q. So no stock on this list meets the requirements and did it with recurring product revenue.

This shows how rare the hyper growth and profitability of XCHO is. Right now it is the only one in its class for growth.

Even though almost all the stocks make that screen with non-recurring event not product sales like XCHO has, how do they do? Screener 123 has built in back tester. Over the last year simply re-balancing each 4 weeks removing stocks that fall off the screen and replacing them with stocks that make the list for for first time, it has done 320% gain compared to about 40% for SP500.

Being that XCHO is beyond the rest for Sequential Growth and is doing it with recurring product sales (Cobroxin OTC Pain Med) they appear to be the fastest growth stock out there. If you know of one with higher growth rates that is Profitable, please post as I will be interested.


Investor Relations:

Management understandably thought that when they reported a profit in 1Q the stock would take off. It did for a while, but we found out very few people were watching XCHO. Thus last week IR was set up.

The IR firm has hired an independent firm that is now writing a Research Report

The reason am aware of this is the company asked my advise on some IR firm candidates and provided them some suggestions. I am very happy with the setup they have created. For full disclosure I am not part of the company, have done this on voluntary basis.

The research firm that has an extensive team of analysts who have worked for hedge-funds and large research outfits such as Alex Brown. The research report, will take several more weeks and then at that time they want to put out the PR about the report. They do not want their name revealed until after the report is released. Their clients are mostly profitable companies and one is a NYSE stock with $1.75 Billion market cap.

In addition the research report the same outfit has an extensive package of radio interviews, webinars, and in person conferences. It will be a solid year of extensive investor relations. So XCHO will go from 10mph to 70 mph in terms of IR overnite.

In addition to that XCHO has stated using the services of another form, Precision IR, to broadcast all the info generated by the Xenacare and the research outfit when that is available. It goes to all the major investor services such Zacks, IB, etc and their own email list. http://www.precisionir.com/index.aspx

XCHO will be able to see how that works out first before committing to longer term with them. I have got Precision IR emails of company events from other companies already. They have 2500 companies using them. If you go to Yahoo quote page http://finance.yahoo.com/q?s=XCHO.OB for XCHO, you will see a button that says “download annual report” It goes to http://www.precisionir.com
You can sign-up there to get email alerts on PR releases, SEC reports etc., as they come out on XCHO.

So Xenacare will both have research report and extensive events calendar from one firm to get the story out to investors and the broadcasting services of another to spread that info far and wide.

Marketing:
The President of Xenacare Frank Rizzo has an extensive marketing background with Rexall-Sundown, Armstrong World Industries (the flooring people) and others. If you check the PR list for XCHO you will see mentions of TV ad campaign, magazines, and other venues. They have a new TV ad with 30 sec and 60 sec versions that was up on YouTube but has been taken down. It is very effective and professional. Recently they did the Balancing Act TV show on Lifetime TV. You can view that at home page of Cobroxin here http://www.cobroxin.com/ Again a very profession presentation. The testimonials are real customers, but I wish they had said what the problem was that Cobroxin solved instead of just saying it works. The interview of Rik was great. The bottom line is literally that they made a profit in the 1st Q of 2010 which shows they know how to spend marketing dollars effectively.


Conclusion:

The Risk/Reward Ratio on XCHO is extraordinary and a 10-20-50 bagger is feasible. Please do your own due diligence.

Chart From FuturesJackal:

I found this website www.trialtrade.com which I thought was pretty cool for stock/financial search. Hope you all like it too.

Good Luck WallStreetMan!

Good Morning Everyone,
I am giving up my Moderator positions on IHUB.
I have always wanted to work in Investor Relations
and will be starting my own business once I move to Florida
and take care of the necessary filings of Incorporation
I wish all the best of luck in your trading
Sincerely
Wallstreetman

UVE selected financial information
UNIVERSAL INSUR HLDG (AMEX:UVE)

PTSC note of personal confidence. I am almost certain that more agreements have been resolved, but not announced , as the legal ends, have not been inked.


disclaimer; Opinion on a hunch only! I have no proof to prove my statement. Total hunch! Common sense in reality, bends me towards believing my statement. They would not be buying back the warrants and giving up usefull cash to buy other acqusitions if they did not know they had more cash coming into the vault.

--------------

a re-post! Cause I believe in this hunch as reasonable.

BUGS is the play on Hurricane Dean ,it is up 47% today and will breakout above .015

thank you :)

I would imagine if the UFC wants to buy out SSPE,they will make a per share offer and if accepted by the company,you would be paid whatever amount the company agreed to per share and they become part of a private company.Sometimes the offer is a good one,then other times it isnt much more then the stock is trading for,especially when everyone starts buying on the news,thinking their going to become millionaires,lol
Good luck
WSM

Wallstreetman I have a question. I was having a conversation with a friend of mine about company buyouts. We were discussing the possibility of (sspe) sun sports entertainment being bought out by the UFC ultimate fighting championship. The UFC does that alot so the odds are there. My question is what if that happens? The ufc is not a public traded company but the company is worth like a billion or so. Would that be good as long as its not a hostile takeover? Thanks for your time I know how busy you are. :)

ADDL is at a 52 week low and a hurricane is developing and it is being watched on two models.This is one of the better Hurricane plays..They supply blue roofs and men faster then any other companies and also have access to the most manpower,that is why FEMA gave them 60 million dollars in contracts in 2005,and by the way ,they were trading at.38 at the time.

BNPD,This stock is acting like it has wings.Up another 25% today
The stock closed at .01 and then at 16:03 a buy went thru for 500,000 shares for .0109.I took some of the DD from the BNPD board I hope they dont mind

http://www.ladypink.us/

DD Link => http://investorshub.advfn.com/boards/read_msg.asp?message_id=21557027
http://investorshub.advfn.com/boards/read_msg.asp?message_id=21591786

DD Link on the Energy Drink Market => http://investorshub.advfn.com/boards/read_msg.asp?message_id=21609104
http://investorshub.advfn.com/boards/read_msg.asp?message_id=21609299

Business Description
A team of dedicated professionals within the beverage industry set out to raise the bar by creating the ultimate energy drink. With energy drinks currently saturating the beverage market place, this would be a challenging task, since this new energy drink would have to meet the following strict criteria:

* Great flavor
* Same immediate 'boost' found in most energy drinks
* Sustainable energy, not just a short burst
* No added caffeine
* No sugar
* No carbs
* No calories
* No after-taste like with most energy drinks
* No 'sudden drop' later on
* Vitamins and minerals added for health-conscious lifestyles
* Only natural additives in a superior formula

With school systems across America banning traditional soda and energy drinks because of adverse side effects and unhealthy additives, the team experimented with hundreds of variations of natural additives to finally obtain incredible effects and taste, but without the negative side effects.

The team interviewed people from all walks of life. They paid close attention to those individuals that currently depend upon energy drinks for performance. The input was carefully calculated so they could create the ultimate energy drink. Some of those consulted included U.S. Army Rangers, U.S. Navy SEALS, Delta Force members, Airborne troops, college students, professional bartenders, doctors, nurses, beverage consultants, engineers, sales professionals, investors, construction workers, computer technicians, truck drivers, pilots, insurance brokers, entertainers, actors, professional athletes, models, investment bankers, secretaries, pastors, housewives and even average people on the street.

The outcome of this intense research and development has resulted in producing the ultimate energy drink . . . Lady Pink Energy Drink!

Agreed MCCY is going to go huge :)

sorry, that's what happens when you go on line late in the day, lol:)
Go DGIA!

EXPH,Im going to post an update for IBN4profits,contribution ,
Expo Holdings, Inc. Progresses to Prototype Phase With Hardware Giant Stanleyworks, Inc.
Tuesday August 7, 9:00 am ET

NORTH WILKESBORO, NC--(MARKET WIRE)--Aug 7, 2007 -- Expo Holdings, Inc. (Other OTC:EXPH.PK - News), through its wholly owned subsidiary D&D Displays, Inc., enters a new phase of its relationship with Hardware Giant Stanleyworks, Inc.


According to J.D. Brown, Chairman and CEO of Expo Holdings, Inc., "We feel the opportunity presented to us as a result of our meetings is an extremely positive one. Stanleyworks is a true giant in the retail / financial world and we are pleased to present prototypes for their use. Typically, prototypes are part of the final phases before a contract is awarded. Our expectation is to serve this customer on a large scale. We will alert our shareholders once contracts/orders have been received. Expo has focused on industry leaders like Stanleyworks for the past year and we have been very successful at diversifying our business with these market leaders."

Stanleyworks, Inc. is a publicly traded company with a market cap of over 4 billion. Stanleyworks and its affiliated brand names including Stanley and Bostich are household names. The Stanleyworks employs over 20,000 people according to the company's website www.stanleyworks.com.

Expo Holdings operates in North Wilkesboro, NC. D&D Displays, is a wholly owned subsidiary of Expo Holdings, which specializes in custom cabinetry and high end store fixtures for retail vendors such as Lowe's, Newell-Rubbermaid, Inc., Bosch Tool Corporation, Kronotex, USA, and S&K Men's Wear. D&D Displays has been in operation since 2000 and joined Expo Holdings in 2006.

TWRT has a great foothold in that business. They dont dilute there stock and continue to improve there process.

Hey John ,should have posted this one earlier its up 80% today ,lol

Welcome Venture,glad to have you contributing
Walt

I remember flying over some farmlands last year and thats all you saw on all the properties those wind towers.I remember saying to my wife, thats going to be a big thing as the years go bye.

Hi Walt!

Your boardmarked...will contribute when I can.

I bought Tower Tech about a year ago. Tower Tech Holdings, Inc.; Headquartered in Manitowoc Wisconsin, Tower Tech Holdings, Inc. is dedicated to the exclusive mass-production of large wind tower support structures, wind turbine assemblies and monopiles for the multi-million-dollar wind power industry. Located on a 46-acre peninsula, Tower Tech leases or has options to lease more than 700,000 square feet of heavy manufacturing under roof. Tower Tech Holdings believes that it has one of the largest capacities of any wind tower manufacturer in North America, and its ability to integrate the entire manufacturing process at its Wisconsin facility as well as source materials and ship finish product by rail sets the Company apart from other manufacturers. Tower Tech Holdings, Inc is currently under manufacturing contracts with the largest global manufacturers of integrated wind energy systems, and is in negotiations with multiple customers for access to the Company's 2007 and 2008 manufacturing capacity.


http://investorshub.advfn.com/boards/board.asp?board_id=8008

IPHE looks like a neat small company 9mil float with plans to go to the OTC soon. Will add more info on it.

I bought Smith & Wesson about a year ago (I like guns). It seems to be pretty stable...

The post split people are whacking it down.
Once that's over and it gets some eyes on it
and a better trading range I think it does real nice.

Thanks for pointing out it is a hurricane play.Another week or so and we will see all these Hurricane plays coming into play for the next two months.

Kesselring recently became public thru a reverse merger with
a simultaneous 1.5 mil. private placement. They are in the commercial and condominium exterior restoration, building, and construction products manufacturing in coastal FLa. and Wash. with pro forma annualized revenues of approximately $12,000,000. So, in effect, they are an excellent hurricane
play stock.

Good Morning Everyone and Welcome Cargo Hauler and Pelagic Mariner.
PM maybe you could give us some DD about the Company and what they actually do,thanks.
CH ,glad to see you posting,sorry about that vacation being over,lol
WSM

Good morning, nice board.
Consider KSSH. Recently did a 19.5-f/s. Very few eyes
on it...yet. I hold shares from before the split.

Posted by: dijeetyet
In reply to: dijeetyet who wrote msg# 188 Date:7/31/2007 1:30:05 PM
Post #of 203

KSSH 34 mil shares and 13 mil revenues

just found this on dpdw board---these #'s from last year and at the time dpdw had 74 mil shares


Pro forma revenues for the year ended December 31, 2006, was $8,821,149, an increase of $3,403,277 or 62.8%, compared to $5,417,872 for the comparable period in 2005. After adjustments for non-cash, non-operating compensation expense of $3,340,792 in 2006, and non-cash, non-operating interest expense ($423,258 in 2006, and $381,310 in 2005) related to the issuance of various preferred shares in the acquisition of Strategic Offshore Services Corporation and Deep Down, Inc. (Delaware), adjusted pro forma net income for the fiscal year ended December 31, 2006, was $952,423, up $350,584 or 58.3%, from $601,839 for the comparable period in 2005. Adjusted pro forma EBITDA for the fiscal year ended December 31, 2006, was $1,296,218, up $242,890 or 23.1%, from $1,053,328 for the comparable period in 2005.

Try SEWC for a longer term hold, huge news could hit at any time and a record volume yesterday may mean a huge follow through today...

The breakout started for SEWC yesterday, should continue today... Incredible penny stock imo...

SewCal Logo Inc. (SEWC: OTCBB) is located in Los Angeles, California. It produces and manufactures custom sportswear and apparel and provides an in-house, full-service custom design center. It currently generates approximately 2 million dollars in annual revenues and carries $250,000 cash on the balance sheet. There are only 27,080,702 million shares outstanding. (*July 2007 SEC filing)

Amazingly, the company is yet undiscovered by the small cap investor masses and has a share price that has quietly traded sub-penny for almost a year with a current share price of only .003 and a market cap of only $82,000! (*July 2007 SEC filing.)

Few people are aware of the incredible developments that are occurring which could quickly catapult the share price to incredible highs within the next few weeks.

SEWCAL RAMPING UP

SewCal is quietly ramping up to launch a new branded line of Surf and Sports Wear clothing named Pipeline Posse to be released in Pacific Sunwear Inc. (NASDAQ: PSUN) and other retail stores worldwide this fall!
From their July SEC Filing: “A line of clothing has been developed and advertising and promotional campaigns are initiated and underway. This new segment of our business is expected to provide a significant increase in revenues resulting within the next 18 months… We have developed the necessary relationships, executed exclusive marketing and advertising programs with some of the top names in the Surfing World, designed an initial line of related surf and sports clothing, created and activated an on-line retail store for Pipeline Posse, and are planning a Summer - Fall 2007 launch of these products into selected retail stores… as a result of leasing an additional 10,000 square feet within our occupied facility as it became available when the former tenant moved out. This additional space, several offices and an inventory / shipping area, are devoted exclusively to our new brand and product development initiated to provide company growth in these new areas.” (*July 2007 SEC filing.)

Several popular small cap investor sites are quietly discussing the new launch and in fact one investor was able to attend the new Pipeline Posse, Project 1 movie premier in San Diego, California and speak with one of founding members of Pipeline regarding the new brand clothing launch. (*Search - Pipeline Posse – Project 1 Movie)

Member writes, “… Just wanted to give you an update on my visit to the Wavehouse on July 14th. Got to see the premier of the Pipeline Posse Project 1 movie, but importantly got a chance to talk to Jamie Sterling. With the new clothing launch coming this fall I wanted to know which stores the Pipeline Posse would be launched and I was excited to hear they would be in Pacific Sunwear. Pacific Sunwear carries many well known surf and skate brands including Roxy, Quiksilver, Hurley, Volcom, Element & Billabong and i believe Pipeline is going to be an incredible addition. We could see a big move in the weeks leading up to the new school year. Good luck to us and hold your shares!”

http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_S/threadview?m=tm&bn=44058&tid=...

From Argyll on the 101 board

How Speculators Exploit Market Fears

by Ben Stein
Thursday, August 2, 2007

Here's a fact: The speculators and hedge fund managers who run today's stock market need market volatility in order to make money.

They can't make enough money if the market stays flat or moves only a bit, so they like extreme and unexpected price movements. They especially like sudden, surprise movements down, when they can make money off stocks they borrow and sell -- or, as they say, "sell short."

Money Lust Satisfied

That's what's been happening the past couple of weeks. But it's not interesting to say that the speculators are whipping the market around to satisfy their money lust. So the speculators themselves make up reasons for why the market is fluctuating, flog those reasons to the media, and then profit if some other speculators believe the jive reasons and jump in the way the manipulators want them to.

Supposedly, the market is "correcting" because of worries about the housing slowdown, and also because of fears that the debt markets that support mergers and acquisitions is drying up.

These are interesting theories, and people who don't know a lot about the stock market or the economy might find them beguiling. What follows are a few truths that show how shallow these "reasons" for the stock market moves are.

Housing a Theory

Yes, the housing market has slowed from a spectacular bubble level to a simply pretty good level. Housing sales and starts are now about what they were in 2002, and no one thought we were in a housing depression then.

In any event, housing is only about 5 percent of the economy. If it falls by 15 percent, that would represent a fall-off of about .75 percent. That's not trivial, but it's also not the stuff of which recessions are made.

The fact is that there is no recession. The economy is suffering from a labor shortage, not a surplus of unemployment. The Fed is worried about excess demand, not slack demand.

Corporate profits set new records every day. Whatever's happening in residential sales and building is simply not slowing down the economy. Why should a Boeing or a Merck or a Pfizer have any reaction to housing at all? Because the speculators sell everything they can when nervousness sets in -- and for no other reason.

A Minor Major Mess

Subprime is a mess. But it's a small mess. Subprime mortgages account for roughly 20 percent of mortgages even in the most heavily exposed states. About 20 percent of them are delinquent in some way. That's 4 percent of mortgages.

Of these, maybe half, or 2 percent, will go into foreclosure. There will be roughly 50 percent recovery on sale of these. This is a loss of 1 percent in the mortgage market -- a sum the lenders have already made many times over because of the hefty fees on those deals. In the context of the size of the U.S. financial sector, it's nothing.

And why should a crisis in subprime drive down stocks in Mexico and Thailand? Again, because the speculators seek to create panic to make money by selling short, and they sell short everything.

There's simply no connection between subprime and developed or developing nations' stocks. This by itself shows the thin context of the selling wave late last month.

Money's Still Cheap

What about the supposed drying up of loans for mergers and acquisitions by private equity firms? Well, here's a good, simple test of just how valid that explanation is for stock market moves: The majority of private equity takeovers are financed with junk debt.

If there really were a major shortage of funds for these deals, the interest rate on the junk would skyrocket. Instead, while the rate has risen by about 150 basis points in the past month, the spread between junk and investment grade is now about 290 basis points, according to leading junk analyst Martin Fridson.

This is a lot lower than the year-end average of the spread from 2002 to 2006, and far below the almost 800 basis point spread during a true interest-rate crunch like the one after the tech meltdown in 2000-2002.

So that's phony, too. Interest rates have risen, but not anything like what they've done in real crises. And besides, the Dow fell by about 550 points the week before last, yet not one of the Dow stocks is involved as either acquiror or acquiree in a private equity deal.

In short, money is no longer virtually free the way it was for private equity deals in the past year. But it's not expensive by historical standards, either.

Spreading the Fear

In other words, it's all the speculators trying to panic us so their sell programs will make money. And they'll make money as long as they can spread their panic. When they can't do that any longer, they'll work the long side -- and make up reasons for that, too.

In the meantime, the economy is strong. Profits are great, and interest rates are low and will stay that way. Don't sell. With all the shrieking about the market, it only fell to what it was about five weeks ago -- and we didn't think we were poor then.

So let the speculators shout "fire." As of right now, they're not blowing anything but smoke.

Coming from You,Im sure it will be great stuff,:)

Hey Walt .....Great board !! I'll post something when I dig up some juicy DD !!

WEGI,Another Hurricane Stock,
I'm sure Brikk doesnt mind me taking some info from his IBOX,lol

Windswept Environmental Group, Inc., through its subsidiaries, provides emergency response, remediation, and disaster restoration services in the United States. It provides services in the areas of emergency response and catastrophe restoration, microbial remediation, site restoration, mold contamination remediation, commercial drying, and natural resource/wetlands. The company also provides restoration/wildlife rehabilitation, forensic investigation, asbestos abatement, fire and flood restoration, demolition, lead abatement, underground storage tank removal, soil remediation, chemical spill response, duct cleaning, indoor air quality investigation, environmental and health and safety training, environmental testing, and environmental consulting services. Its customers primarily include insurance companies, industrial businesses, construction companies, oil companies, utilities, banks, school districts, state, local and county governments, commercial building owners, real estate developers, and residential real estate owners. The company was incorporated in 1986 under the name International Bankcard Services Corporation and changed its name to Windswept Environmental Group, Inc. in 1997. Windswept Environmental Group is based in Bay Shore, New York.

Company Website: http://www.tradewindsenvironmental.com/splash.html

Recent Press Releases: http://finance.yahoo.com/q?s=WEGI.OB

Current Share Structure:
Authorized 120,000,000
Outstanding 40,395,626
Non-Restricted 20,258,315

ADDL,formerly ZENX, is strictly a Hurricane Play. They are a roofing company that also specializes in "Blue Roofs".
In 2005,the Horrific Hurricane year for the southern states ,ZENX was trading in the .30's when it was awarded a 20 million dollar contract by FEMA.
The stock immediately started moving and the following week FEMA added another 40 million dollar contract.The stock went to 1.45 in a very short period .
I have been watching the stock coming back down to the low .40's,where on July 17 it reached .41
and although on low volume started moving slowly back up to .46,closing on a down friday trading day at .44

The difference betwen ZENX of 2005 and ADDL of 2007, is one word.Aquisitions.
In late 2006 picking up Mint Construction Co. and Brent Andersen Associates.
This year they are in the process of picking up Hayden Construction,West Nyack,N.Y .$5,600,000 annual sales and 40 of it's own employees.
They entered 2007 with a backlog of 23.8 million,and in the first 5 months of 2007 have been awarded 22.2 million in new contracts.

This is FEMA's most reliable Company for Blue Roofs.Thay are capable of Having hundreds of roofers on the job in a matter of days and that is
what makes them the top choice in disaster situations.
With August right around the corner,and the beginning of the serious Hurricane season,I see ADDL,starting to get more attention.
At .44 this might be our last chance to enter in the low .40's
I recently went down to Florida to purchase a home. Port St.Lucie being one of my stops.After talking to many residents,
the wife and I walked away with the impression that these residents weren't talking "if a hurricane comes,but more when the hurricane comes"
We decided to purchase in a more inland community.
Florida residents,myself soon to be considered one,are fortunate to have companies like ADDL,
that are capable of supplying 100's of men and equipment in a couple of days notice.
Let's hope that ADDL will
not be needed,but I am sure they are prepared for the Challenge.

Good morning

Good Morning All

Jack,the stock I'm counting on to pay for the new home is DGIA.
I know the complete history of this company and have met the CEO Les Eveneshen in New York at one of their seminars.
If there hasn't been any chnages I will be meeting him and the President Brian Conrad friday of this week or early next week.They will be in NY to meet with the Directors of INXR,who they will be representing in seminars starting this October.
This is one of those rare situations that a company became a public traded company without having a market maker to represent them.This left them open to be slaughtered by the other MM's.That is being taken care of and it will start trading at it's true value,which I believe is somewhere between .25 and .50 short term.
I believe DPDW is a good solid play and CTUM is only a couple of months away from getting FDA approval.KSW is my Long Term solid play on the Big Boards.

thanks for the info...im looking into it. it may go up if its decent....but its almost at the bottom now so not much more to go

You might want to check out INXR, according to the company they are working on audited financials now and expect to have them out soon in order to become eligible for uplisting. Could run hard when they come out or not do anything.

Well that is a research project. Anyone have another answer?

It truely is an interesting topic. One that I never assumed!

IWEB - great little company, with millions of dollars in government contracts. It's been pumped a bit lately, but I think its a good longer term hold for $2.50 - $3.50 range. I'm looking to add shares around .70 support area. First quarter 07 shows a profit for the first time. I expect Q2 financials to look even better.

SHARE STRUCTURE
* 1B Authorized
* 11.4M Outstanding
3.3M Float
* per Olde Monmouth Stock Transfer

Recent Headlines on Yahoo:

http://finance.yahoo.com/q?s=iweb.ob

Most recent 10Q:

http://yahoo.brand.edgar-online.com/fetchFilingFrameset.aspx?dcn=0001144204-07-022717&Type=HTML

IHub IceWEB board:

http://investorshub.advfn.com/boards/board.asp?board_id=5196

wallstreet, those are some interesting picks...im currently researching them...i noticed one of them is talking about uplisting...i like those picks. If you had to pick your 3 top picks for stocks you fel will do well with some time what would they be? I'm with slon, sspe, pown if i can find what will make a good addition. I know what you mean about being in many stocks....sometimes i wish i had the money for more buys..like now theres good ones. Here's a interesting 60 mins video on mixed martial arts..the money is really there$$$$

http://www.cbsnews.com/stories/2006/12/08/60minutes/main2241525_page3.shtml

Hi Jack,we dont want you talking to yourself on this board,lol
We all cant be in every stock we like so I try and put the stocks in an order I feel they might move.Most of the time it can work out well and of course there are the times you miss a nice run,but that's the market.
I like SSPE for a play later in the month.Right now I am expecting Good News from DGIA,actually was expecting it last thursday so if it isnt out this week,I would be very surprised to say the least.OBFM ,EXPH,and MCCY should be active plays this week.Toward the 15th,I will be looking to enter ADDL and DPDW.I expect weather conditions will be changing by that time and the quarterly reports should be good for both of these companies.
Toward the end of the month I will be looking to enter SSPE with their events in the beginning of Sept and NXNO who might be settling their law suits by August 30,2007 in their favor.JMO of course,LOL

hi wallstreetman, sspe does move easy....kinda like slon...you blow on it and it shows....i was in the first big move which was up to .33 from like .04.....what do you think of the stock??? on the sspe section of ihub i feel like im talking to myself lol

It is an interesting subject.So is your friend saying that Shareholders of Record are actually Brokers holding shares for their clients.That would make sense except when we see 999 Shareholders of Record,they can't be all brokers.
Anyone else have an opinion of what Constitutes "Shareholders of Record".I once owned a few hundred shares of a stock in certificate form,I imagine I would have qualified at that time as a Shareholder of Record.

I received a clearification from a friend on the matter of shareholder count. It is classified as brokerages under the term "Street name." The link below explains it.


Street Name
Term used when securities are held in the name of a broker or other nominee rather than the investor. Because the broker is holding the securities, it is easier to make a transfer of them at the time of sale. If the stock were registered in the investor's name and physically held by him or her, transfer of shares would take longer.

http://www.answers.com/topic/street-name?cat=biz-fin

Hi TechKim,this was released friday by CNLG,


Conolog Launches New Comprehensive and Interactive Product Website www.iniven.com

SOMERVILLE, N.J., Aug. 3 /PRNewswire-FirstCall/ -- Conolog Corporation (Nasdaq: CNLG), an engineering and design company that provides digital signal processing solutions to global electric utilities, announced today the launch of a comprehensive and detailed interactive website that incorporates all protection products, system details, technical literature, installation/wiring diagrams and online order entry for worldwide applications, at http://www.iniven.com.

President of Conolog Marc Benou stated, 'Our new website provides our customers with detailed information on any of our products including specifications from our manuals.'

Benou added, 'With the continuing expansion of our product line, it became necessary to provide much more information to an ever increasing customer base. The new website format allows us to do this and leaves room for our anticipated expansion.'

About Conolog Corporation

Conolog Corporation is a provider of digital signal processing and digital security solutions to electric utilities worldwide. The Company designs and manufactures electromagnetic products to the military and provides engineering and design services to a variety of industries, government organizations and public utilities nationwide. The Company's INIVEN division manufactures a line of digital signal processing systems, including transmitters, receivers and multiplexers. For more information, visit http://www.iniven.com.

Contact: Conolog Corporation: Robert Benou, Chairman, 908/722-8081

ource: PR Newswire (August 3, 2007 - 8:00 AM EST)

CNLG - Iraq power grid! Headline news this weekend.

remember this distributor
Conolog Appoints JAL International as Exclusive Contractor/Rep/Distributor for the Middle East With Offices in the Kingdom of Saudi Arabia and Emirates
http://biz.yahoo.com/prnews/070605/netu038.html?.v=10

Iraq’s national electricity grid nearing collapse is the headline news this weekend.
Residents ‘fed up’ as power, water become increasingly scarce
http://www.msnbc.msn.com/id/12784358/
================================================================
INIVEN is a division of Conolog Corporation (established 1969). Conolog Corp. is a communications manufacturer of hi-reliability MILITARY and commercial products.
Conolog Corp. acquired INIVEN in 1980. When acquired, INIVEN manufactured FSK (frequency shift keyed) audio communications products. The product line has been expanded to include audio and digital teleprotection, substation multiplexers, and a more sophisticated line of FSK telemetry terminals. All products feature DSP (digital signal processing) and microprocessor technology.
================================================================


CONOLOG CORP (NasdaqCM:CNLG)

How is it now AUdad?lol

Add the link to your board as your siggy, and as your quote you could say sometime like we research stock picks here. Check out Ricks siggy and it will give you an idea. GL!